European Journal of Heart Failure·29 SepEffectiveness of Finerenone in Slowing Chronic Kidney Disease Progression After Hospitalization for Heart Failure: A FIDELITY Subgroup AnalysisRandomised trial in peopleFinerenonePaper
Nature Medicine·1 SepShort-term effects of combinations of heart failure therapies on blood pressure, kidney function and serum potassiumTrial in peopleInterventionsPaper
European Journal of Heart Failure·30 AugTime in blood pressure range and cardiovascular outcomes in HFmrEF/HFpEF: a pooled participant-level analysis of four large-scale trialsTrial in peoplePopulationsPaper
European Heart Journal·18 AugFinerenone benefits in patients with cardio-kidney-metabolic syndrome with or without history of cancer: the FINE-HEART pooled analysisTrial in peopleInterventionsPaper
Journal of Cardiac Failure·11 AugThe HFpEF-ABA Score, Incident Heart Failure, and Finerenone in Chronic Kidney Disease with Type 2 DiabetesRandomised trial in 11,950 peopleFinerenonePaper
AAIC 2025 Abstract·25 DecGlucose lowering treatment in high fat diet‐induced cognitive impairment indicates that cognitive deficits may be glucose independentExperiments in animalsInterventionsPaper
AHA Scientific Sessions 2025 Abstract·3 NovFinerenone Reduces Loop Diuretic Requirement in Patients with Type 2 Diabetes and CKD: Participant-Level Pooled Analysis of FIDELIO-DKD and FIGARO-DKDTrial in peopleInterventionsPaper
AHA Scientific Sessions 2025 Abstract·3 NovTiming of Cardiovascular and Kidney Benefits with Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 DiabetesTrial in peopleInterventionsPaper
AHA Scientific Sessions 2025 Abstract·3 NovInterplay Between Heart Failure Progression, New-Onset Diabetes, and Finerenone: A FINEARTS-HF AnalysisTrial in peopleInterventionsPaper
AHA Scientific Sessions 2025 Abstract·3 NovSymptoms of Bladder Incontinence Are Associated with Worse Functional Status and Quality of Life in Heart Failure with Preserved Ejection FractionStudy in peoplePopulationsPaper
AHA Scientific Sessions 2025 Abstract·3 NovMajor Adverse Cardiovascular Events across the Spectrum of Cardio-Kidney-Metabolic Syndrome: A FINE-HEART Pooled AnalysisTrial in peopleInterventionsPaper
AHA Scientific Sessions 2025 Abstract·3 NovThe HFpEF-ABA Algorithm and Finerenone in Chronic Kidney Disease with Type 2 Diabetes: A FINE-HEART AnalysisTrial in peopleBiomarkersPaper
AHA Scientific Sessions 2025 Abstract·3 NovFinerenone Reduces Sudden Death across the Spectrum of Cardio-Kidney-Metabolism: the FINE-HEART Pooled AnalysisTrial in peopleInterventionsPaper
AHA Scientific Sessions 2025 Abstract·3 NovFinerenone and liver fibrosis assessed by fibrosis-4 (FIB-4) index in patients with heart failure and mildly reduced or preserved ejection fraction: Results from the FINEARTS-HF trialTrial in peopleInterventionsPaper
AHA Scientific Sessions 2025 Abstract·3 NovThe Association of Cardiac Structure and Function with Incident Stroke in Patients with Heart Failure with Preserved Ejection Fraction: Insights from the TOPCAT and PARAGON-HF TrialsTrial in peopleBiomarkersPaper